GlassScriptPhysician profile
Ali Ghazanfari
NPI 1528261732
$17,016.49
in general payments reported to CMS, 2019-2025
28 companies · $1,048 in 2025
The $1,048 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,180 · 2020: $277 · 2021: $586 · 2022: $5,653 · 2023: $995 · 2024: $276 · 2025: $1,048.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623 · Travel and Lodging: $582 · Long Term Medical Supply Or Device Loan: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.96 |
| Travel and Lodging | $581.91 |
| Long Term Medical Supply Or Device Loan | $114.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $6,455.71 | 2019-2020 | |
| Intuitive Surgical, INC. | $4,939.94 | 2022-2023 | |
| Allergan, INC. | $1,780.68 | 2019-2020 | |
| Davol INC. | $1,335.06 | 2020-2025 | Phasix Mesh, Arista Ah Flexitip |
| Medtronic, INC. | $894.49 | 2021-2025 | Sonicision, Dextile, Maxtack |
| Kowa Pharmaceuticals America, INC. | $534.23 | 2022-2023 | Seglentis |
| Integra Lifesciences Corporation | $178.50 | 2024-2025 | Integra, Cytal, Integra Dermal Regeneration Template |
| Olympus America INC. | $145.19 | 2021 | |
| Merck Sharp & Dohme LLC | $95.06 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.71 | 2019 | |
| Inspire Medical Systems, INC. | $73.90 | 2023 | Inspire |
| Innocoll Pharmaceuticals Limited | $68.52 | 2021-2022 | |
| Ethicon US, LLC | $50.20 | 2019-2024 | Dermabond, Stratafix, Ethicon |
| Boston Scientific Corporation | $40.05 | 2023-2025 | General - Pain Management |
| Mimedx Group, INC. | $35.95 | 2024-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $34.75 | 2023-2024 | Tisseel, Perclot |
| Innovation Technologies INC | $32.33 | 2023-2024 | Irrisept |
| Acell, INC. | $26.90 | 2020 | |
| Acacia Pharma INC | $25.82 | 2021 | |
| Tela Bio, INC. | $24.96 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medela LLC | $24.71 | 2020-2021 | |
| Dilon Technologies, INC. | $24.53 | 2023 | Hemoblast Bellows |
| Coloplast Corp | $22.68 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.23 | 2024 | Exparel |
| Nalu Medical, INC. | $17.66 | 2023 | Nalu Neurostimulation System |
| Kci USA, INC. | $15.55 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.52 | 2021 | |
| Teleflex LLC | $11.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Ghazanfari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.